Assertio Therapeutics to Report Second Quarter 2019 Financial Results After The Close of Markets on Wednesday, August 7, 201...
July 17 2019 - 4:05PM
Assertio Therapeutics, Inc. (NASDAQ:ASRT) today announced that it
will release second quarter 2019 financial results on Wednesday,
August 7, 2019, after the close of markets. Following the
announcement, the Company will host a conference call beginning at
4:30 p.m. ET to discuss its results.
Participants can access the live webcast from
the Investor Relations section of Assertio's website at
http://investor.assertiotx.com. Please access the website 15
minutes prior to the start of the call to download and install any
necessary audio software.
Audio Conference
Call:
U.S. Dial-in
Number: |
1-877-550-3745 |
International Dial-in Number: |
1-281-973-6277 |
Conference ID: |
7769879 |
An archived webcast replay will be available on
the Company's website accessed by visiting
http://investor.assertiotx.com.
About Assertio Therapeutics,
Inc.Assertio Therapeutics is committed to providing
responsible solutions to advance patient care in the Company’s core
areas of neurology, orphan and specialty medicines. Assertio
currently markets three FDA-approved products and continues to
identify, license and develop new products that offer enhanced
options for patients that may be underserved by existing therapies.
To learn more about Assertio, visit www.assertiotx.com.
Investor and Media Contact:John
B. Thomas Senior Vice President, Investor Relations and Corporate
Communications jthomas@assertiotx.com
Assertio (NASDAQ:ASRT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Assertio (NASDAQ:ASRT)
Historical Stock Chart
From Sep 2023 to Sep 2024